The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
maybe not in barmy boris land, but pretty sure it is widespread elsewhere and it not just about covid, there are thousands of applications, for tests that need to be administered and know doubt thousands more in the future.
obviously Mullis could only see his 8 mil bonus and targeted achieving it, as for current CEO, well I am beginning to think that he already knew, what his end result would be, before even starting and why he acts like a chocolate fireguard (absolutely useless) and just plays the patsey? That or he was selected because those hiring knew he would be one from the outset?
all imo dyor roll on dhsc settlement spike...
"This would help explain why the AIM submission document referred to the Lab21 deal as Novacyt acquiring Lab21 through a reverse merger."
The AIM document called it a reverse merger (which is a takeover) because that's what it was.
Here's NCYT shareholders advisors for the takeover, an investment banking firm and not a Spanish blogger https://www.micheldyens.com/selected-transactions/lab21-has-acquired-novacyt-novacyt-was-advised-by-michel-dyens-co
Dev Clever didn't takeover Veative, they took over a subsidiary called Veative Labs and paid Veative in Dev Clever shares.
Shares paid was about 20% of Dev Clevers new float, the sub Veative Labs was 25% the size of Dev so it's a straight swap, note 20% is not a majority same as 46% isn't a majority yet a takeover.
Also CEO of VLPL Ankur Aggarwal the much bigger parent company joined the Dev Clever BoD and exe team, not quite CEO he still has his day job to do, but still broadly the same as GM taking over.
It's tenuous using that as an example, it's a totally different situation. dev clever took over a smaller company owned by a much larger company and paid the larger company in shares and giving it a top CXO role so yeah it's kinda a reverse takeover cos Veative Labs was smaller and their boss is kinda taking over running Dev, but he's also boss of a company much bigger than Dev. the Veative CEO is getting 30mm shares just for himself
Lab21 took over a larger company and paid in shares and took the top job. That's a straight forward reverse takeover
Regardless what you posted matches what I say. Getting 20% of the float and a top job is a reverse takeover, getting 46% of the float and the top job is also a reverse takeover.
Although there are numerous articles out there that say Dev Clever took over Veative
https://newsnreleases.com/2021/04/12/dev-clever-to-acquire-veative-labs-pte-ltd-for-approximately-54-75-million/
Geez, now if I was a childish idiot, why I could claim.......................
"Testing isn't going anywhere!"
But the fun bit is that as well as abnormally emotionally attached to a Plc, they are also massively childish so they have to pretend that this global investment banking firm that advised NCYT SH on their takeover is a blogger called Michel
https://www.micheldyens.com/selected-transactions/lab21-has-acquired-novacyt-novacyt-was-advised-by-michel-dyens-co
BH, bb's are all about sharing research and knowledge so just wanted to share something regarding Dev Clever who recently purchased Veative. Dev Clever are listed and the acquired company Veative is private yet the FCA deemed it a reverse takeover despite Dev being the acquirer. Basically, same transaction as Novacyt and Lab21. Below is extract from Dev RNS:
The Company immediately began working with its professional advisers towards the publication of the prospectus to enable transaction iii) to complete. During this process, the FCA indicated to the Company that it considered that the completion of transactions i) and ii) on 12 April 2021 constituted a reverse takeover under Listing Rule 5.6.4.
The RNS is date 19th July 2022. Take a look and see what you think.
Check out the definition of a reverse takeover according to the FCA. Reverse doesn't just mean a private company buying a listed company.
This would help explain why the AIM submission document referred to the Lab21 deal as Novacyt acquiring Lab21 through a reverse merger.
digby I can assure you a lot more than two of the baldies were coming at me. I find it interesting that adults could be so emotionally attached to a Plc. I had 10k invested here, lot less now of course, I'm invested in several other shares too, I don't feel this cultish attachment to any of them for me they are just investments.
I actually try to find companies to invest in that I think will be taken over so I can make money. Mention NCYT been taken over or poss of Bio taking over and the investors here reach for the pitchforks and act like it's a dirty thing instead of a payday. Why?
"has willy checked out the link" that's it you crack on with your disrespect for other posters, as long as that makes you feel good.
Oh er Willy a simple answer A) or answer B) would have been good, so it is beyond your capabilities to spot the difference between an investment banking firm and a Spanish blogger.
Yeap exmex. Normal people don't live on here all day. Better things to do
It's been like watching 2 bald men fighting over a comb.
It seems that the midnight rambling one is stuck in a loop . Reminds me of this old Monty Python clip.
https://youtu.be/xpAvcGcEc0k
Im more intrested if they got dues from algimed
Lab 21 merges with cervical cancer screening firm novacyt.............. Pointless noise
"has willy checked out the link" that's it you crack on with your disrespect for other posters, as long as that makes you feel good.
still only understanding the takeover bit and not the reverse part.
Hardly unexpected from someone who 'mistakes' a global investment firm for a blogger.
has willy checked out the link yet
https://www.micheldyens.com/selected-transactions/lab21-has-acquired-novacyt-novacyt-was-advised-by-michel-dyens-co
You said "The UK has voted to leave the EU by 52% to 48%. " and I agreed they left. Just like the Novacyt vote to be taken over.
You have now jumped to share holders.
WRONG. Novacyt didn't get anything, shareholders in the old Novacyt were allocated shares in the new Novacyt entity (by GM) they are all independent shareholders nothing to do Novacyt, it's just a business vehicle. The shares issued to them in the new Novacyt was payment for agreeing to be taken, they didn't buy them, issued one for one according to their holding in the old Novacyt.
Nothing to do with any vote, once the takeover was agreed old Novacyt stopped existing. Hence the new shares.
This is a bb for shareholders but neither of you understand the concept. Once shares are issued, they're gone, the company doesn't own them anymore the shareholder does, the fact that 54% of shares went to people who had been invested in Novacyt means nothing, counts for nothing. Those people have nothing to do with the company. Unless they have enough shares to matter.
Wilson, it doesn't matter if Lab21 had 1 shareholder who got all 46%. Yes it would give them significant influence but not overall control. Lab21 probably had several investors with the biggest probably getting 10% of Novacyt. No where near enough for control.
We all wait weeks/months for rns's. We wait 6-12 months for the accounts yet when they finally arrive BH completely disregards what's in them. Instead he waits for the article from small time Marcel. Bizarre really.
This all comes from the guy that will try to convince you that Microgen is just being rebranded and they'll be no redundancies and the £500k restructuring costs is because we now have to employ several more accountants so Microgen can meet the new set of regulations of being a public company. Whaaaaat.
Did you check out the link Willy
My goodness you are holier than thou and you also using Drb's words and attributing them to me you seem good at that.
My point was the Brexit vote was 52-48 you knew that Novacyt got 54per cent of the shares you knew that, but because you presume(may be accurate) less people at lab21 got the 46 per cent they would have more power(again a presumption on your part), so stop treating everything you state as fact and start being a bit more humble it wouldn't hurt to try.
Bulletin boards are made for all shapes and sizes and people with different abilities and life experiences a large number of people on this board have been helpful and enlightening to many try it without being condescending.
BH, I'll stick with the RNS system, the annual accounts and the AIM submission document. You can stick with Michel if you prefer. Stop hogging the board posting the only article that you can find that incorrectly supports your warped theory. Shall we now move on.
The word is 'Bearing'
It's not banter.
The Brexit it bit is why I consider you an idiot.
"The UK has voted to leave the EU by 52% to 48%. " excusing the bad grammar you should have stopped there. Nothing else is needed, the UK voted, the UK left. Where the voters lived doesn't matter, just their eligibility.
Same with Novacyt shareholders voting to be taken over by Lab21, it didn't matter where the shareholders lived, just that they were eligible to vote.
So, no you left, as you correctly said the UK voted to leave, it left. Novacyt voted to get taken over by Lab21, it was.
Here is a link, also a chance to prove you're not too much of an idiot. Follow the link and see how you get on (feel free to look around).
Do you see
A) the impressive client list of a global investment banking firm who advised Novacyt shareholders on their takeover by Lab21
b) a blog by some bloke called Michel
https://www.micheldyens.com/selected-transactions/lab21-has-acquired-novacyt-novacyt-was-advised-by-michel-dyens-co
"Lab21 has acquired Novacyt. Novacyt was advised by Michel Dyens & Co.
Novacyt (NYSE-ALTERNEXT: ALNOV), is a leading diagnostics manufacturer that develops and markets innovative solutions in liquid-based cytology for the detection of cancer, including cervical cancer and other non-gynaecological cancers, and Lab21 is a UK-based global specialist in personalized medicine and clinical diagnostics.
The combined group will create an emerging diagnostics leader with a portfolio of cancer and infectious diseases diagnostic products and services.
Michel Dyens & Co was the exclusive financial advisor of Novacyt’s shareholders on their M&A strategy, and ultimately the stock-for-stock transaction with Lab21."
Baring in mind BH describes me as an idiot (and other things which in modern day speak is bullying however I'm a Neanderthal and know he/she/it is just having bantz, that's me getting down with it!!)
I thought I'd use an example that an idiot like me can understand, oh no remain leave discussion it's just one we are all familiar with.
Brexit
The UK has voted to leave the EU by 52% to 48%. Leave won the majority of votes in England and Wales, while every council in Scotland saw Remain majorities
So we remained correct?
I'm also good at reversing.
"I don't think I'm humouring him B2. I think he's genuinely confused and way out of his depth in business. I'm happy to help fellow investors learn and understand things but Huey took it a little too far. Point taken though."
Was it ever about Lab21?
Got the the impression it was more about having a childish pop at me.
And now you're left looking very childish. Because...............
https://www.micheldyens.com/selected-transactions/lab21-has-acquired-novacyt-novacyt-was-advised-by-michel-dyens-co
"Lab21 has acquired Novacyt. Novacyt was advised by Michel Dyens & Co.
Novacyt (NYSE-ALTERNEXT: ALNOV), is a leading diagnostics manufacturer that develops and markets innovative solutions in liquid-based cytology for the detection of cancer, including cervical cancer and other non-gynaecological cancers, and Lab21 is a UK-based global specialist in personalized medicine and clinical diagnostics.
The combined group will create an emerging diagnostics leader with a portfolio of cancer and infectious diseases diagnostic products and services.
Michel Dyens & Co was the exclusive financial advisor of Novacyt’s shareholders on their M&A strategy, and ultimately the stock-for-stock transaction with Lab21."
Michel Dyens & Co is not a blogger
Stop being a child in trying to bully others off this bb, you haven't got the skills for it. take this as a lesson and grow up.
Huey, why is it relevant to Lab21 being discontinued?
You're the only person that believes that Michel Dyens & Co is some bloke called Michel and their client list is an article written by this Michel person.
The rest of the world says
So..........
https://www.micheldyens.com/selected-transactions/lab21-has-acquired-novacyt-novacyt-was-advised-by-michel-dyens-co
"Lab21 has acquired Novacyt. Novacyt was advised by Michel Dyens & Co.
Novacyt (NYSE-ALTERNEXT: ALNOV), is a leading diagnostics manufacturer that develops and markets innovative solutions in liquid-based cytology for the detection of cancer, including cervical cancer and other non-gynaecological cancers, and Lab21 is a UK-based global specialist in personalized medicine and clinical diagnostics.
The combined group will create an emerging diagnostics leader with a portfolio of cancer and infectious diseases diagnostic products and services.
Michel Dyens & Co was the exclusive financial advisor of Novacyt’s shareholders on their M&A strategy, and ultimately the stock-for-stock transaction with Lab21."
Why do you think it's a blogger called Michel.
Huey, all you've got is Michel. I'm not the only one saying his terminology is wrong. Graham Mullis is, Novacyt are in their rns's, Novacyt are in their annual accounts, Novacyt are in their AIM submission document that you kindly posted. Numerous investor articles are. It's not just me. I personally don't know why he termed it incorrectly like that. You'd have to ask him.
I see you're struggling to move on from this and keep ignoring my question of why it is relevant today. After all, the debate started with Lab21 being discontinued.